Copy to clipboard 
DJO Global posted 4Q17 revenue of US $312.2MM, +5.3% vs. 4Q16, and 2017 of $1,186.1MM, +2.7% vs. 2016.
ORTHOWORLD estimates segment sales and growth as follows.
| 4Q17 | 4Q16 | $ Change | % Change | |
| Joint Reconstruction | $70.9 | $58.1 | $0.2 | 22.1% |
| Knee | $19.2 | $15.4 | $0.2 | 24.4% |
| Hip | $16.7 | $14.0 | $0.2 | 19.5% |
| Extremities | $35.0 | $28.7 | $0.2 | 22.2% |
| Other* | $241.3 | $238.4 | $0.0 | 5.3% |
| Total | $312.2 | $296.5 | $0.1 | 5.3% |
| 2017 | 2016 | $ Change | % Change | |
| Joint Reconstruction | $253.6 | $209.6 | $43.9 | 21.0% |
| Knee | $68.1 | $55.3 | $12.7 | 23.0% |
| Hip | $60.3 | $48.6 | $11.7 | 24.2% |
| Extremities | $125.2 | $105.7 | $19.5 | 18.4% |
| Other* | $932.6 | $945.7 | -$13.2 | -1.4% |
| Total | $1,186.1 | $1,155.4 | $30.8 | 2.7% |
*Includes Bracing/Vascular, Recovery Sciences and also International revenue not already attributed to Joint Recon
Leadership expects orthopaedic product sales will continue to be a growth driver in 2018. New product launches for Surgical Implants will commence in 2Q in hip, knee and shoulder.
While not sold under the Surgical Implant segment, at AAOS DJO launched the X4 Smart knee brace for total knee arthroplasty that monitors patient recovery and compliance in real time, enabling on-demand patient/physician connectivity.
Source: DJO Global
DJO Global posted 4Q17 revenue of US $312.2MM, +5.3% vs. 4Q16, and 2017 of $1,186.1MM, +2.7% vs. 2016.
ORTHOWORLD estimates segment sales and growth as follows.
Q17
Q16
$ Change
% Change
Joint Reconstruction...
DJO Global posted 4Q17 revenue of US $312.2MM, +5.3% vs. 4Q16, and 2017 of $1,186.1MM, +2.7% vs. 2016.
ORTHOWORLD estimates segment sales and growth as follows.
| 4Q17 | 4Q16 | $ Change | % Change | |
| Joint Reconstruction | $70.9 | $58.1 | $0.2 | 22.1% |
| Knee | $19.2 | $15.4 | $0.2 | 24.4% |
| Hip | $16.7 | $14.0 | $0.2 | 19.5% |
| Extremities | $35.0 | $28.7 | $0.2 | 22.2% |
| Other* | $241.3 | $238.4 | $0.0 | 5.3% |
| Total | $312.2 | $296.5 | $0.1 | 5.3% |
| 2017 | 2016 | $ Change | % Change | |
| Joint Reconstruction | $253.6 | $209.6 | $43.9 | 21.0% |
| Knee | $68.1 | $55.3 | $12.7 | 23.0% |
| Hip | $60.3 | $48.6 | $11.7 | 24.2% |
| Extremities | $125.2 | $105.7 | $19.5 | 18.4% |
| Other* | $932.6 | $945.7 | -$13.2 | -1.4% |
| Total | $1,186.1 | $1,155.4 | $30.8 | 2.7% |
*Includes Bracing/Vascular, Recovery Sciences and also International revenue not already attributed to Joint Recon
Leadership expects orthopaedic product sales will continue to be a growth driver in 2018. New product launches for Surgical Implants will commence in 2Q in hip, knee and shoulder.
While not sold under the Surgical Implant segment, at AAOS DJO launched the X4 Smart knee brace for total knee arthroplasty that monitors patient recovery and compliance in real time, enabling on-demand patient/physician connectivity.
Source: DJO Global
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
